SWCRF collaborator Prof. Shai Izraeli appointed Director of Hematology-Oncology Department at Schneider Children’s Medical Center
|Prof. Shai Izraeli|
The Samuel Waxman Cancer Research Foundation (SWCRF) congratulates its longtime scientific collaborator Prof. Shai Izraeli on his recent appointment to Director of the Department of Hematology-Oncology at Schneider Children’s Medical Center. He succeeds Prof. Isaac Yaniv, who has retired after a distinguished tenure at the medical center.
Prof. Izraeli’s SWCRF-funded work in blood malignancies, in collaboration with fellow SWCRF grantees John Crispino, Ph.D., Northwestern University, and Sai-Juan Chen, M.D., Ph.D., of the Shanghai Institute of Hematology, has appeared in leading scientific journals and has made him an in-demand speaker on hematology and general cancer research.
“It is a pleasure to congratulate our longtime distinguished collaborator and friend Shai Izraeli on this new professional achievement,” said Samuel Waxman, M.D., Founder and CEO of the Samuel Waxman Cancer Research Foundation. “Shai’s scientific contributions to the SWCRF and the international hematology field position him very well to accomplish great things in his new leadership role at Schneider Children’s Medical Center.”
Prof. Izraeli previously served as the Director of the Unit of Functional Genomics, and Childhood Leukemia and Cancer Research at Sheba Medical Center Tel Hashomer. He holds the Dora and Georgio Shapiro Chair and Head of the Dotan Center for Research of Blood Malignancies at Tel Aviv University. His breakthrough research in Molecular Biology and Genomics has led to the discovery of a new form of childhood leukemia. These findings have been translated globally into the routine diagnosis of children with leukemia and clinical trials with targeted medications in the USA in children and adults with the type of cancer identified by Prof. Izraeli’s team.
Prof. Izraeli has produced over 160 publications that have appeared in prestigious scientific journals. As the recipient of many international awards, he is in demand as a lecturer all over the world. He is a member of the select Executive Board of the European Hematology Association. His “I Believe” is that advanced basic and clinical research is vital to fulfil the vision to cure every child with cancer or severe blood disease.
The Hematology-Oncology Department at Schneider Children’s is a national referral center for children with blood diseases and cancer from all over the country and is the largest of its kind in Israel. The department comprises Inpatients, Day Care, Ambulatory Clinics, Specialized Clinics, and Diagnostic and Research Laboratories. Multidisciplinary teams provide comprehensive care to the child and his family. Pediatric oncologists in the department follow international treatment protocols thus ensuring the most advanced care to children with cancer in Israel, and are leaders in progressive research of blood malignancies and cancer in children.